Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Nishimura, N."" wg kryterium: Wszystkie pola


Tytuł:
Report of Two Contrasting Cases of Epstein–Barr Virus–Associated Hemophagocytic Lymphohistiocytosis: Comparison to Infectious Mononucleosis and Flow Cytometric Analysis of Bone Marrow
Autorzy:
Ono S
Yoshimoto K
Matsubara M
Nishimura N
Kawashima H
Yoneima R
Yada N
Nishio K
Pokaż więcej
Temat:
epstein-barr virus infection epstein-barr virus–associated hemophagocytic lymphohistiocytosis diagnosis of ebv-hlh flow cytometric analysis of bone marrow
Medicine (General)
R5-920
Źródło:
International Medical Case Reports Journal, Vol Volume 17, Pp 43-49 (2024)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/report-of-two-contrasting-cases-of-epsteinbarr-virusassociated-hemopha-peer-reviewed-fulltext-article-IMCRJ; https://doaj.org/toc/1179-142X
Dostęp URL:
https://doaj.org/article/4799778125f3484b854970e0662b578c  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World Data
Autorzy:
Miyake M
Nishimura N
Shimizu T
Ohnishi M
Kuwada M
Itami Y
Inoue T
Ohnishi K
Matsumoto Y
Yoshida T
Tatsumi Y
Shinohara M
Hori S
Morizawa Y
Gotoh D
Nakai Y
Anai S
Torimoto K
Aoki K
Fujii T
Tanaka N
Fujimoto K
Pokaż więcej
Temat:
urinary bladder neoplasms
immunotherapy
chemotherapy
survival
propensity score
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło:
Cancer Management and Research, Vol Volume 14, Pp 623-635 (2022)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/significant-improvement-of-prognosis-after-the-advent-of-immune-checkp-peer-reviewed-fulltext-article-CMAR; https://doaj.org/toc/1179-1322
Dostęp URL:
https://doaj.org/article/69b11219af0f44e087084bee0729a7da  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
High-resolution measurement of hypernuclear events in a nuclear emulsion with hard X-ray microscopy
Autorzy:
Kasagi, A.Aff1, Aff2, IDs10050022008307_cor1
Hayashi, K.
Lin, P. M.
Nakazawa, K.Aff1, Aff3
Nishimura, N.
Nyaw, A. N. L.
Saito, T. R.Aff2, Aff4, Aff5
Yoshida, J.Aff2, Aff6, Aff7
Yoshimoto, M.Aff3, Aff8
Pokaż więcej
Źródło:
The European Physical Journal A: Hadrons and Nuclei. 58(10)
Czasopismo naukowe
Tytuł:
The Ventilatory Strategy to Minimize Expiratory Flow Rate in Ventilated Patients with Chronic Obstructive Pulmonary Disease
Autorzy:
Tsuboi N
Tsuboi K
Nosaka N
Nishimura N
Nakagawa S
Pokaż więcej
Temat:
copd
tracheomalacia
fluid dynamics
minimized expiratory flow rate ventilation
flow-controlled ventilation.
Diseases of the respiratory system
RC705-779
Źródło:
International Journal of COPD, Vol Volume 16, Pp 301-304 (2021)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/the-ventilatory-strategy-to-minimize-expiratory-flow-rate-in-ventilate-peer-reviewed-article-COPD; https://doaj.org/toc/1178-2005
Dostęp URL:
https://doaj.org/article/cca49e07f8ff4aea8968e15ee05b963a  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Successful thoracoscopic operative approach for refractory pneumothorax in interstitial lung disease under local anaesthesia.
Autorzy:
Yamanaka S; Department of Internal Medicine St. Luke's International Hospital Tokyo Japan.
So C; Department of Pulmonary Medicine, Thoracic Center St. Luke's International Hospital Tokyo Japan.
Nishimura N; Department of Pulmonary Medicine, Thoracic Center St. Luke's International Hospital Tokyo Japan.
Nakamura T; Department of Pulmonary Medicine, Thoracic Center St. Luke's International Hospital Tokyo Japan.
Kabemura S; Department of Thoracic Surgery, Thoracic Center St. Luke's International Hospital Tokyo Japan.
Kumagai R; Department of Thoracic Surgery, Thoracic Center St. Luke's International Hospital Tokyo Japan.
Okafuji K; Department of Pulmonary Medicine, Thoracic Center St. Luke's International Hospital Tokyo Japan.
Kitamura A; Department of Pulmonary Medicine, Thoracic Center St. Luke's International Hospital Tokyo Japan.
Kojima F; Department of Thoracic Surgery, Thoracic Center St. Luke's International Hospital Tokyo Japan.
Tomishima Y; Department of Pulmonary Medicine, Thoracic Center St. Luke's International Hospital Tokyo Japan.
Jinta T; Department of Pulmonary Medicine, Thoracic Center St. Luke's International Hospital Tokyo Japan.
Bando T; Department of Thoracic Surgery, Thoracic Center St. Luke's International Hospital Tokyo Japan.
Pokaż więcej
Źródło:
Respirology case reports [Respirol Case Rep] 2024 Mar 25; Vol. 12 (3), pp. e01331. Date of Electronic Publication: 2024 Mar 25 (Print Publication: 2024).
Typ publikacji:
Case Reports
Raport
Tytuł:
Tofogliflozin Delays Portal Hypertension and Hepatic Fibrosis by Inhibiting Sinusoidal Capillarization in Cirrhotic Rats.
Autorzy:
Asada S; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Kaji K; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Nishimura N; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Koizumi A; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Matsuda T; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Tanaka M; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Yorioka N; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Sato S; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Kitagawa K; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Namisaki T; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Akahane T; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Yoshiji H; Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Mar 19; Vol. 13 (6). Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:
Journal Article
MeSH Terms:
Endothelial Cells*/pathology
Hypertension, Portal*/drug therapy
Benzhydryl Compounds*
Glucosides*
Rats ; Male ; Animals ; Rats, Inbred F344 ; Liver Cirrhosis/pathology
Czasopismo naukowe
Tytuł:
Black esophagus: a life-threatening adverse event associated with endoscopic retrograde cholangiopancreatography.
Autorzy:
Kitagawa K; Department of Gastroenterology, Nara Medical University, Nara, Japan.
Masuda H; Department of Gastroenterology, Nara Medical University, Nara, Japan.
Mitoro A; Division of Endoscopy, Nara Medical University, Nara, Japan.
Tomooka F; Department of Gastroenterology, Nara Medical University, Nara, Japan.
Asada S; Department of Gastroenterology, Nara Medical University, Nara, Japan.
Nishimura N; Department of Gastroenterology, Nara Medical University, Nara, Japan.
Kaji K; Department of Gastroenterology, Nara Medical University, Nara, Japan.
Yoshiji H; Department of Gastroenterology, Nara Medical University, Nara, Japan.
Pokaż więcej
Źródło:
Clinical endoscopy [Clin Endosc] 2024 Mar; Vol. 57 (2), pp. 270-273. Date of Electronic Publication: 2023 May 23.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver Cirrhosis.
Autorzy:
Suzuki J; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Namisaki T; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Takya H; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Kaji K; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Nishimura N; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Shibamoto A; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Asada S; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Kubo T; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Iwai S; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Tomooka F; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Takeda S; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Koizumi A; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Tanaka M; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Matsuda T; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Inoue T; Department of Evidence-Based Medicine, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Fujimoto Y; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Tsuji Y; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Fujinaga Y; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Sato S; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Kitagawa K; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Kawaratani H; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Akahane T; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Mitoro A; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Matsumoto M; Department of Hematology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Asada K; Clinical Research Center, Nara Medical University, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Yoshiji H; Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 26; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
von Willebrand Factor*/metabolism
Venous Thrombosis*/complications
Humans ; Portal Vein/metabolism ; ADAMTS13 Protein ; Prognosis ; Japan ; Liver Cirrhosis/pathology ; Biomarkers
Czasopismo naukowe
Tytuł:
Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors.
Autorzy:
Shimizu T; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Miyake M; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Nishimura N; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Yoshida T; Department of Urology, Nara Prefecture Seiwa Medical Center, Ikoma, Nara 636-0802, Japan.
Itami Y; Department of Urology, Tane General Hospital, Osaka, Osaka 550-0025, Japan.
Tachibana A; Department of Urology, Hoshigaoka Medical Center, Hirakata, Osaka 573-8511, Japan.
Omori C; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.; Department of Urology, Nara Prefecture General Medical Center, Nara, Nara 630-8581, Japan.
Oda Y; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Kohashi M; Department of Urology, Nara City Hospital, Nara, Nara 630-8305, Japan.
Tomizawa M; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Onishi K; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Hori S; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Morizawa Y; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Dotoh D; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Nakai Y; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Torimoto K; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Tanaka N; Department of Prostate Brachytherapy, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Fujimoto K; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2024 Feb 19; Vol. 16 (4). Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Individual response of humans to ionising radiation: governing factors and importance for radiological protection
Autorzy:
Applegate, K. E.
Rühm, W.
Wojcik, A.
Bourguignon, M.
Brenner, A.
Hamasaki, K.
Imai, T.
Imaizumi, M.
Imaoka, T.
Kakinuma, S.
Kamada, T.
Nishimura, N.
Okonogi, N.
Ozasa, K.
Rübe, C. E.
Sadakane, A.
Sakata, R.
Shimada, Y.Aff12, Aff15
Yoshida, K.
Bouffler, S.
Pokaż więcej
Źródło:
Radiation and Environmental Biophysics. 59(2):185-209
Czasopismo naukowe
Tytuł:
The Hexane Extract of Citrus sphaerocarpa Ameliorates Visceral Adiposity by Regulating the PI3K/AKT/FoxO1 and AMPK/ACC Signaling Pathways in High-Fat-Diet-Induced Obese Mice.
Autorzy:
Zang L; Graduate School of Regional Innovation Studies, Mie University, Tsu 514-8507, Mie, Japan.; Mie University Zebrafish Drug Screening Center, Mie University, Tsu 514-8507, Mie, Japan.
Kagotani K; Mie University Zebrafish Drug Screening Center, Mie University, Tsu 514-8507, Mie, Japan.; Tsuji Health & Beauty Science Laboratory, Mie University, Tsu 514-8507, Mie, Japan.; Tsuji Oil Mills Co., Ltd., Matsusaka 515-0053, Mie, Japan.
Hayakawa T; Tsuji Health & Beauty Science Laboratory, Mie University, Tsu 514-8507, Mie, Japan.; Tsuji Oil Mills Co., Ltd., Matsusaka 515-0053, Mie, Japan.
Tsuji T; Tsuji Health & Beauty Science Laboratory, Mie University, Tsu 514-8507, Mie, Japan.; Tsuji Oil Mills Co., Ltd., Matsusaka 515-0053, Mie, Japan.
Okumura K; Department of Life Sciences, Graduate School of Bioresources, Mie University, Tsu 514-8507, Mie, Japan.
Shimada Y; Mie University Zebrafish Drug Screening Center, Mie University, Tsu 514-8507, Mie, Japan.; Department of Integrative Pharmacology, Mie University Graduate School of Medicine, Mie University, Tsu 514-8507, Mie, Japan.; Department of Bioinformatics, Mie University Advanced Science Research Promotion Centre, Tsu 514-8507, Mie, Japan.
Nishimura N; Graduate School of Regional Innovation Studies, Mie University, Tsu 514-8507, Mie, Japan.; Mie University Zebrafish Drug Screening Center, Mie University, Tsu 514-8507, Mie, Japan.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Dec 09; Vol. 28 (24). Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:
Journal Article
MeSH Terms:
Citrus*/metabolism
Anti-Obesity Agents*/pharmacology
Animals ; Mice ; AMP-Activated Protein Kinases/metabolism ; Mice, Obese ; Phosphatidylinositol 3-Kinases/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Zebrafish/metabolism ; Adiposity ; Hexanes/pharmacology ; Obesity/drug therapy ; Obesity/etiology ; Obesity/metabolism ; Adipogenesis ; Body Weight ; Signal Transduction ; Lipids/pharmacology ; Diet ; Diet, High-Fat/adverse effects ; 3T3-L1 Cells ; Mice, Inbred C57BL
Czasopismo naukowe
Tytuł:
Oral Administration of Rhamnan Sulfate from Monostroma nitidum Suppresses Atherosclerosis in ApoE-Deficient Mice Fed a High-Fat Diet.
Autorzy:
Terasawa M; Konan Chemical Manufacturing Co., Ltd., Kitagomizuka, Kusu-cho, Yokkaichi 510-0103, Japan.; Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Minamitamagaki-cho, Suzuka 513-8670, Japan.
Zang L; Graduate School of Regional Innovation Studies, Mie University, Tsu 514-8507, Japan.
Hiramoto K; Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Minamitamagaki-cho, Suzuka 513-8670, Japan.
Shimada Y; Department of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan.
Mitsunaka M; Department of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan.
Uchida R; Konan Chemical Manufacturing Co., Ltd., Kitagomizuka, Kusu-cho, Yokkaichi 510-0103, Japan.; Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Minamitamagaki-cho, Suzuka 513-8670, Japan.
Nishiura K; Konan Chemical Manufacturing Co., Ltd., Kitagomizuka, Kusu-cho, Yokkaichi 510-0103, Japan.
Matsuda K; Konan Chemical Manufacturing Co., Ltd., Kitagomizuka, Kusu-cho, Yokkaichi 510-0103, Japan.
Nishimura N; Graduate School of Regional Innovation Studies, Mie University, Tsu 514-8507, Japan.
Suzuki K; Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Minamitamagaki-cho, Suzuka 513-8670, Japan.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Nov 20; Vol. 12 (22). Date of Electronic Publication: 2023 Nov 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Atherosclerosis*/metabolism
Chlorophyta*/genetics
Animals ; Female ; Mice ; Diet, High-Fat ; Sulfates ; Inflammation/metabolism ; Administration, Oral ; Apolipoproteins E ; RNA, Messenger/therapeutic use ; Receptors, Cell Surface
SCR Organism:
Monostroma nitidum
Czasopismo naukowe
Tytuł:
A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer.
Autorzy:
Yabuki Y; Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Hanibuchi M; Department of Community Medicine for Respirology, Hematology and Metabolism, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Takeuchi E; Department of Clinical Investigation, National Hospital Organization Kochi Hospital, Kochi, Japan.
Haku T; Department of Respiratory Medicine, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Kanematsu T; Department of Respiratory Medicine, Japanese Red Cross Matsuyama Hospital, Matsuyama, Japan.
Nishimura N; Department of Pulmonary Medicine, St. Luke's International Hospital, Tokyo, Japan.
Toyoda Y; Department of Internal Medicine, Japanese Red Cross Kochi Hospital, Kochi, Japan.
Mitsuhashi A; Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Otsuka K; Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Sato S; Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Goto H; Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Yoneda H; Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Ogino H; Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Nokihara H; Department of Respiratory Medicine, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
Tsutomu S; Department of Community Medicine for Respirology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Nishioka Y; Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Nov; Vol. 14 (32), pp. 3232-3239. Date of Electronic Publication: 2023 Sep 17.
Typ publikacji:
Multicenter Study; Clinical Trial, Phase II; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Humans ; Aged ; Aged, 80 and over ; Pemetrexed ; Bevacizumab/adverse effects ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies